Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Diatrizoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.31 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diatrizoic Acid SCHEMBL6286191 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2MEN1KMT2ACA1 | |
| Diatrizoic Acid SCHEMBL3076099 | 0.98 | LMNA (0.96) | LMNASMN1; SMN2MEN1KMT2A | |
| Diatrizoic Acid SCHEMBL19379574 | 0.98 | LMNA (0.96) | LMNASMN1; SMN2MEN1KMT2A | |
| Diatrizoic Acid SCHEMBL3338333 | 0.98 | LMNA (0.96) | LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL8815549 | 0.96 | LMNA (0.92) | LMNASMN1; SMN2MEN1KMT2ACA1 | |
| Diatrizoic Acid SCHEMBL7198501 | 0.96 | LMNA (0.92) | LMNASMN1; SMN2MEN1KMT2ACA1 | |
| Diatrizoic Acid SCHEMBL21243193 | 0.93 | LMNA (0.86) | LMNASMN1; SMN2MEN1KMT2A | |
| Iothalamic Acid SCHEMBL159919 | 0.86 | LMNA (0.75) | LMNASMN1; SMN2 | |
| Iothalamic Acid SCHEMBL30496108 | 0.86 | LMNA (0.75) | LMNASMN1; SMN2 | |
| Metrizoic Acid SCHEMBL11334827 | 0.84 | LMNA (0.71) | LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16047 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692793-A1 | BLOOD COLLECTION CONTAINER, AND METHOD FOR SEPARATING MONONUCLEAR CELLS | Sekisui Medical Co., Ltd. (JP) | 2026-02-11 | — | — | EP | claimed |
| US-20260028586-A1 | METHODS FOR PRODUCING CELL POPULATIONS WITH INCREASED NUCLEIC ACID UPTAKE | ZEON CORPORATION (JP) | 2026-01-29 | — | — | US | claimed |
| US-12493029-B2 | Compositions, methods, and kits for the isolation of extracellular vesicles | EXOSOME DIAGNOSTICS, INC. (US) | 2025-12-09 | — | — | US | claimed |
| WO-2025202247-A1 | A METHOD OF SEPARATING TARGET CELLS FROM NON-TARGET CELLS IN A LIQUID BIOPSY SAMPLE, AND A KIT THEREFOR | OSAID MOHAMMAD (SE) | 2025-10-02 | — | — | WO | claimed |
| WO-2025124483-A1 | ORAL DRUG DOSAGE FORM FOR TARGETED DRUG DELIVERY BASED ON TRACKING MARKER AND METHODS OF DESIGN AND USE THEREOF | Triastek, Inc. (CN) | 2025-06-19 | — | — | WO | claimed |
| WO-2025121491-A1 | METHOD FOR PRODUCING TONSIL-DERIVED MESENCHYMAL STEM CELLS | 연세대학교 원주산학협력단 | 2025-06-12 | — | — | WO | claimed |
| WO-2025107704-A1 | NEW-TYPE ANTIFOULING DEVELOPING COATING MATERIAL, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州银炙新材料科技有限公司 | 2025-05-30 | — | — | WO | claimed |
| US-20250154554-A1 | ANTIMICROBIAL SUSCEPTIBILITY | FASTINOV, SA (PT) | 2025-05-15 | — | — | US | claimed |
| EP-4543498-A2 | COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING | Suntec Medical, Inc. (US) | 2025-04-30 | — | — | EP | claimed |
| CN-119897141-A | Porous rod-like carbon nitride photocatalytic material and preparation method and application thereof | 东南大学 | 2025-04-29 | — | — | CN | claimed |
| US-5415546-A | Markers | COX SR RONALD W (US) | 1995-05-16 | — | — | US | claimed |
| WO-1994021190-A1 | RADIOPAQUE DENTAL COMPOSITE AND MATERIALS | COX RONALD W (US) | 1994-09-29 | — | — | WO | claimed |
| US-5260186-A | Isolation of lymphocytes, centrifuging | CERCEK BORIS (US) | 1993-11-09 | — | — | US | claimed |
| US-5149712-A | Treatment of corneal edema with diatrizoate solutions | SCHACHAR RONALD A (US) | 1992-09-22 | — | — | US | claimed |
| EP-0439548-A1 | PROVISION OF DENSITY SPECIFIC BLOOD CELLS FOR THE STRUCTUREDNESS OF THE CYTOPLASMIC MARIX (SCM) TEST. | CERCEK BORIS (US) | 1991-08-07 | — | — | EP | claimed |
| WO-1990004785-A1 | PROVISION OF DENSITY SPECIFIC BLOOD CELLS FOR THE STRUCTUREDNESS OF THE CYTOPLASMIC MATRIX (SCM) TEST | CERCEK BORIS (US) | 1990-05-03 | — | — | WO | claimed |
| US-4735795-A | Alkylammonium complexes of diatrizoic acid as X-ray contrast agents | E. R. SQUIBB & SONS, INC. (US) | 1988-04-05 | — | — | US | claimed |
| EP-0028842-A2 | Improved medium for the separation of human blood leucocytes | Ferrante, Antonio (AU) | 1981-05-20 | — | — | EP | claimed |
| US-4255256-A | HIGH MOLECULAR WEIGHT SUCROSE OR GLUCOSE POLYMER AND A WATER SOLUBLE METRIZOATE OR DIATRIZOATE COMPOUND | FERRANTE ANTONIO | 1981-03-10 | — | — | US | claimed |
| US-4192859-A | MEDICAL DIAGNOSIS USING X-RAYS | E. R. SQUIBB & SONS, INC. (US) | 1980-03-11 | — | — | US | claimed |